Reportable segment data as of, or for, each period presented in the consolidated statements of income and comprehensive income, the consolidated balance sheets, and the consolidated statements of cash flows is as follows:


	Three Months Ended December 31, 2025						Three Months Ended December 31, 2024
	Tobacco Operations		Ingredients Operations		Consolidated		Tobacco Operations		Ingredients Operations		Consolidated
Sales and other operating revenues	$	779,946	$	81,342	$	861,288	$	853,884	$	83,309	$	937,193
Cost of goods sold	(634,173)		(67,527)		(701,700)		(678,885)		(64,720)		(743,605)
Selling, general and administrative expenses	(48,583)		(11,218)		(59,801)		(58,178)		(11,875)		(70,053)
Corporate overhead allocated to the segments	(14,403)		(2,723)		(17,126)		(16,404)		(3,055)		(19,459)
Equity in pretax earnings (loss) of unconsolidated affiliates (1)	1,257		—		1,257		2,149		—		2,149
Segment operating income	84,044		(126)		83,918		102,566		3,659		106,225
Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates (1)					(1,257)						(2,149)
Restructuring and impairment costs (2)					(711)						—

Consolidated total					$	81,950					$	104,076


	Nine Months Ended December 31, 2025						Nine Months Ended December 31, 2024
	Tobacco Operations		Ingredients Operations		Consolidated		Tobacco Operations		Ingredients Operations		Consolidated
Sales and other operating revenues	$	1,944,065	$	265,162	$	2,209,227	$	1,996,051	$	248,954	$	2,245,005
Cost of goods sold	(1,576,708)		(218,974)		(1,795,682)		(1,616,797)		(195,554)		(1,812,351)
Selling, general and administrative expenses	(133,394)		(35,296)		(168,690)		(138,383)		(36,527)		(174,910)
Corporate overhead allocated to the segments	(50,132)		(9,478)		(59,610)		(48,164)		(8,970)		(57,134)
Equity in pretax earnings (loss) of unconsolidated affiliates(1)	1,131		—		1,131		1,647		—		1,647
Segment operating income	184,962		1,414		186,376		194,354		7,903		202,257
Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates(1)					(1,131)						(1,647)
Restructuring and impairment costs (2)					(1,833)						(10,573)

Consolidated operating income					$	183,412					$	190,037

(1)Equity in pretax earnings (loss) of unconsolidated affiliates is included in segment operating income (Tobacco Operations), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

(2)Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income. See Note 2 for additional information.


	Segment Assets						Accounts Receivable, net
	December 31, 2025		December 31, 2024		March 31, 2025		December 31, 2025		December 31, 2024		March 31, 2025
Tobacco Operations	$	2,498,015	$	2,517,063	$	2,436,416	$	517,732	$	590,731	$	566,755
Ingredients Operations	519,499		523,356		553,136		53,779		59,290		59,121
Consolidated total	$	3,017,514	$	3,040,419	$	2,989,552	$	571,511	$	650,021	$	625,876

	Goodwill, net						Intangibles, net
	December 31, 2025		December 31, 2024		March 31, 2025		December 31, 2025		December 31, 2024		March 31, 2025
Tobacco Operations	$	97,730	$	97,751	$	97,772	$	59	$	58	$	47
Ingredients Operations	116,068		116,068		116,068		50,576		60,386		57,789
Consolidated total	$	213,798	$	213,819	$	213,840	$	50,635	$	60,444	$	57,836

					Capital Expenditures				Depreciation and Amortization
					Nine Months Ended December 31,				Nine Months Ended December 31,
					2025		2024		2025		2024
Tobacco Operations					$	24,673	$	30,127	$	24,505	$	29,603
Ingredients Operations					15,630		24,758		15,701		14,951
Consolidated total					$	40,303	$	54,885	$	40,206	$	44,554